1600002H07Rik Inhibitors
Chemical inhibitors of 1600002H07Rik function by interacting with various signaling pathways that regulate the activity of this protein. Staurosporine, a pan-kinase inhibitor, can inhibit a wide range of kinases, leading to the inhibition of 1600002H07Rik by preventing its phosphorylation or activation. Similarly, LY294002 and Wortmannin, both PI3K inhibitors, can inhibit the PI3K/AKT pathway, which is often involved in regulating proteins like 1600002H07Rik. PD98059 and U0126, as MEK inhibitors, can prevent the activation of the MAPK/ERK pathway, a potential regulator of 1600002H07Rik, thereby inhibiting its function. SB203580 specifically inhibits p38 MAPK, another pathway that can modulate the function of 1600002H07Rik.
Further, SP600125 blocks the JNK signaling pathway, which can lead to the inhibition of 1600002H07Rik by preventing its activation by JNK kinases. ZM-447439, an Aurora kinase inhibitor, can interfere with mitotic processes, possibly inhibiting 1600002H07Rik if it is involved in cell cycle regulation. Dasatinib and PP2 target a broad spectrum and specific tyrosine kinases, respectively, which can disrupt various signaling pathways and inhibit the function of 1600002H07Rik. Leflunomide, by inhibiting dihydroorotate dehydrogenase, can affect the synthesis of pyrimidines, thus potentially inhibiting the function of proteins like 1600002H07Rik that may be involved in cell proliferation. Lastly, Bortezomib inhibits the proteasome system, which can lead to the accumulation of proteins that regulate the stability and degradation of proteins like 1600002H07Rik.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent pan-kinase inhibitor which can inhibit a broad range of kinases within cellular signaling pathways, leading to the functional inhibition of 1600002H07Rik by preventing its phosphorylation or activation through those kinases. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, a kinase involved in the AKT signaling pathway. By inhibiting PI3K, LY294002 can lead to a decrease in AKT activation, a pathway that may be involved in the functional regulation of 1600002H07Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which is part of the MAPK/ERK pathway. By inhibiting MEK, PD98059 can prevent the activation of ERK, thereby potentially leading to the functional inhibition of 1600002H07Rik, assuming it is a downstream effector in this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. By inhibiting p38 MAPK, SB203580 can prevent the downstream signaling that may be necessary for the functional activity of 1600002H07Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, thereby blocking the JNK signaling pathway. Inhibition of this pathway can lead to the functional inhibition of 1600002H07Rik by preventing its activation or phosphorylation by JNK. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3K. Inhibition of PI3K can lead to the functional inhibition of 1600002H07Rik by blocking the PI3K/AKT pathway that may be essential for its activation. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor. By inhibiting Aurora kinases, ZM-447439 can interfere with mitotic processes, which could lead to the functional inhibition of 1600002H07Rik if it plays a role in mitosis or cell cycle regulation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor that can inhibit Src family kinases and BCR-ABL. This broad inhibition can lead to the functional inhibition of 1600002H07Rik by disrupting various signaling pathways that rely on these kinases for activation. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases. By specifically inhibiting these kinases, PP2 can lead to the functional inhibition of 1600002H07Rik by disrupting the Src kinase-mediated signaling pathways that are potentially crucial for its function. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
Leflunomide is an inhibitor of dihydroorotate dehydrogenase, which can lead to the functional inhibition of 1600002H07Rik by interfering with pyrimidine synthesis, a process that may be necessary for the function of proteins involved in cell proliferation and DNA synthesis. | ||||||